Short answer
Ardent Health, Inc. (ARDT) filed its Q2 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $1.6B (down 1.4% year over year) with net income of $17M.
Q2 2026 key financials · XBRL
- Revenue
- $1.6B
- −1.4% YoY · +1.3% QoQ
- Net income
- $17M
- −76.8% YoY · −57.6% QoQ
- EPS (diluted)
- $0.12
- −76.9% YoY · −57.1% QoQ
Source: XBRL data from the Ardent Health, Inc. (ARDT) Q2 2026 10-Q on SEC EDGAR. USD.
Ardent Health, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue decreased $23.0M, or 1.4% YoY, driven by lower revenue per adjusted admission
- Adjusted admissions increased 2.5%, while admissions declined 1.0% and surgeries declined 2.9%
- Revenue per adjusted admission decreased 3.9%, including a $57.8M decline in Medicaid supplemental payments
- Medicaid supplemental-payment revenue decreased to $197.1M from $254.9M YoY
- Near-term headwinds: OBBBA Medicaid reductions, expiring ACA subsidies, labor shortages, inflation, and reimbursement pressure
Risk Factors
- No material changes to previously disclosed risk factors from the Annual Report
- Regulatory and compliance risks remain those incorporated from the Annual Report
- Operational and competitive risks remain unchanged from the Annual Report
- Financial risks remain unchanged from the Annual Report
- Stock repurchase authorization $33.7 million remaining as of June 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ardent Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.